Puma Biotechnology has one approved drug, strong cash, and is developing alisertib with key ALISCA trial readouts in 1H 2026.
Q3 2025 Earnings Call Transcript November 5, 2025 Power Integrations, Inc. beats earnings expectations. Reported EPS is $0.36 ...
Duke Energy Corporation ( DUK) Q3 2025 Earnings Call November 7, 2025 10:00 AM EST ...
Q3 2025 Earnings Call Transcript November 6, 2025 Operator: Good day and welcome to the Energy Transfer Q3 2025 Earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback